As with so many core functions of public health, the future success of vaccine promotion research depends on the support of every institution: government, universities, and industry alike.

Isaac Kabrick is a fellow with the Center for Health Policy and the Law at the O’Neill Institute. The son of two nurses, Kabrick is interested in connecting peopl ...

Matt Motta, PhD, is an associate professor at the Boston University School of Public Health’s Department of Health Law, Policy, and Management.

Inhaled corticosteroid–long-acting beta-agonist (ICS-LABA) inhalers are widely prescribed for asthma and chronic obstructive pulmonary disease. ICS-LABAs are largely interchangeable within the class; ...

Burnout and decreased well-being among primary care physicians threaten workforce sustainability and health outcomes. Understanding how primary care physician burnout and its mitigators differ across ...

Community health workers are uniquely suited to help underresourced communities navigate structural barriers and mitigate the ...

Weeks earlier, the New York City Council passed the Guaranteeing Unbiased AI Regulation and Disclosure (GUARD) Act, which ...

Before ChatGPT Health becomes a default destination for people seeking to make sense of their health, we need better evidence ...

This article examines the PBM-related provisions in the 2026 Consolidated Appropriations Act in the context of other federal and state efforts to regulate PBMs, then offers recommendations on ...

P. Paul Chandanabhumma, PhD, MPH, is an assistant professor in the Department of Family Medicine and leadership member of the Mixed Methods Program both at the University of Michigan.

For decades, mpox did not pose a threat to Americans, but that changed rapidly and repeatedly over the past five years.

Christine Ritchie ([email protected]), Massachusetts General Hospital and Harvard University, Boston, Massachusetts. Bruce Leff, Johns Hopkins University, Baltimore, Maryland. The COVID-19 pandemic ...